Primo Brands (Thermos, ReadyRefresh, Mountain Valley) reported Q1 2026 net revenues of $1.63B, above analyst estimates. Q2 is peak season for bottled water in North America (summer). The $1.60B threshold is 1.8% below Q1 – a conservative bar. 19 analysts cover the stock; average price target $27.91 (+20%). No prediction market; own estimate 72%.
National Beverage (LaCroix) generated FY2026 (ending May 2026) revenues of $1.2B – quarterly average ~$300M. Q1 FY2027 ends in July 2026, peak summer for US sparkling water. The $290M threshold is slightly below the quarterly average. Special dividend of $3.25/share paid July 1, 2026, and $350M cash signal financial strength. Q1 FY2027 EPS consensus: $0.60. No prediction market; own estimate 70%.
AB InBev delivered Q1 2026 underlying EPS of USD 0.97 (record Q1, +20.8% vs Q1 2025; consensus of USD 0.90 clearly beaten). H1 2025 underlying EPS was USD 1.79 (Q1: USD 0.80; Q2: USD 0.98). For H1 2026 EPS to exceed USD 2.00, Q2 must deliver at least USD 1.03 — only a 5.1% increase vs Q2 2025. Given ongoing megabrand premiumization, FIFA World Cup volume acceleration (Budweiser as global beer partner), and the active share buyback, this appears highly likely. H1 results on July 30, 2026. No prediction market found.
Kirin reported Q1 FY2026 net profit of JPY 27.1B and EPS of JPY 33.46 (+11.3% YoY). H1 FY2025 EPS was JPY 70 (profit JPY 57.2B). FY2026 full-year guidance: EPS JPY 193 (net profit JPY 156B, +5.7% YoY). With Q1 already at JPY 33.46, Q2 FY2026 only needs approx. JPY 34.54 to hit the JPY 68 threshold — roughly in line with estimated Q2 FY2025 levels (~JPY 36–40). Key risks — Middle East material costs (up to ▼JPY 20B) and Four Roses divestiture (▼JPY 7–8B) — are predominantly H2-weighted. No prediction market found.
TWE has reiterated its FY2026 EBIT guidance of AUD 480–490M multiple times, most recently in the Q2 2026 interim update. The AUD 478M threshold is just below the guidance floor (AUD 480M). Key risks — Penfolds sales in China (post-2024 tariff removal) and US restructuring after H1 impairment — are already factored into guidance. Positive depletions trends are viewed as a stabilization signal. 14 analysts: Buy, avg. target AUD 5.43. Fiscal year ended June 30, 2026; results on August 13, 2026. No prediction market found.
Coca-Cola reports Q2 2026 on 28 July 2026 before market open. Analyst consensus: $0.93 adjusted EPS (Barchart/MarketBeat, July 2026; range $0.92–$0.94). In Q1 2026, Coca-Cola beat consensus by ~13%, confirming the company's historically high beat rate (>75% of quarters). The separately captured organic revenue growth >3.5% signals pricing strength supporting earnings. Analysts highlight 'resilient demand' (Proactive Investors). This prediction is substantively separate from the existing organic-growth prediction. No Polymarket signal for KO Q2 EPS.
The AHDB malting barley reference price (CIF UK ports) stood at £157/t in February 2026, down 21.5% YoY (from £200/t). Drivers: UK brewers, maltsters and distillers cut barley usage in H1 2025-26 by 17% (164,000t) — the largest half-year drop since records began in 1990. Causes: US tariffs (10%) on Scotch whisky weakening export distilling; structurally declining beer and spirits demand. UK spring barley sown area 2026 fell 15% to 612,000ha. A rise above £175/t by end of August requires a demand recovery not visible in brewery or distillery data.
Monster Beverage reports Q2 2026 results on July 30, 2026 (after market close). Analyst consensus EPS is USD 0.58. In Q1 2026 Monster beat the USD 0.5354 estimate by +8.33%; in Q4 2025 it exceeded consensus by +6.25%. Q1 2026 revenue surged 26.9% to USD 2.35 billion — an unusually strong pace pointing to sustained consumer demand and distribution gains. A 2-for-1 stock split is also pending (record date July 24, distribution August 10), typically accompanied by solid fundamentals. No prediction market found. The combination of a consistent beat track record and growth momentum yields an estimated beat probability of 70%.
Campari achieved +2.9% organic growth in Q1 2026 (net sales EUR 643 million) and confirmed its full-year guidance of ~3% organic growth. Highlights: Developing markets +12.7%, North America +2.2%, Europe +1.9%, APAC/GTR −1.6%. H1 results typically appear in late July (H1 2025: July 31). The H1 2026 Aide-Mémoire is already listed on camparigroup.com. Agave portfolio (+4.9%) and aperitifs (+2.1%) provide structural tailwinds into Q2. No Polymarket/Kalshi market found.
Celsius generated record Q1 2026 revenue of USD 782.6 million (+138% YoY) through full consolidation of Alani Nu (USD 368 million) and Rockstar (since August 2025). Q2 2026 is the first period with both brands for a full quarter and benefits from the seasonal summer energy-drink peak. Q2 analyst consensus: ~USD 910 million. Threshold of USD 850 million is ~6.6% below consensus — a conservative hurdle. Celsius beat Q1 estimates by +2.5% (USD 782.6M vs. USD 763.8M consensus). No Polymarket/Kalshi market available.
Diageo releases FY2026 annual results and Strategy Update on August 6, 2026. Company guidance: organic net sales -2% to -3%. The 9-month performance (Jul 2025–Mar 2026) was -1.9% organic — better than guided. Q3 showed improvement: Europe, LatAm & Caribbean, Africa each high-single-digit organic, supported by FIFA WC-related spirits stocking. Q4 FY26 (Apr–Jun 2026) likely positive from WC TV consumption (whisky, premix). Decline worse than -3% appears ~25% likely. No Polymarket/Kalshi quote available.
AB InBev delivered +5.8% organic revenue growth in Q1 2026 — strongest quarter since Q1 2023 — with first volume growth (+0.8%) in years. Underlying EPS rose +20.8%. 2026 guidance was maintained. Q2 may be slightly softer given tougher comps and macro headwinds (Iran conflict, transport costs), but organic revenue growth should remain well above 3%.
The US-Iran Memorandum of Understanding (MOU) was signed around June 17, 2026 (CNN, Axios, CSIS) and sets a 60-day window for final nuclear negotiations (deadline: ~August 17, 2026). Key outstanding disputes per Al Jazeera (June 23, 2026): uranium enrichment limits, status of highly enriched uranium stockpiles, IAEA verification, sanctions architecture. Historical precedent: JCPOA negotiations 2013–2015 lasted >22 months. Polymarket priced the MOU completion near 100% — this refers to the MOU itself, not a final agreement, which is a significantly higher bar. Most likely scenario: no deal within the deadline, but continuation of talks.